Skip to main content
. 2020 Jun 24;12(6):585. doi: 10.3390/pharmaceutics12060585
ADC antibody-drug conjugate
BareLipo bare liposomes
CHCA α-cyano-4-hydroxycinnamic acid
CHEMS cholesteryl hemisuccinate
DCM dichloromethane
DLS dynamic light scattering
DMF N,N-dimethylformamide
DSPE-PEG 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000
EDC 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
ErbB2Lipo ErbB2-targeting liposomes
HBTU 3-[bis(dimethylamino)methyliumyl]-3H-benzotriazol-1-oxide hexafluorophosphate
HOBt·H2O 1- hydroxybenzotriazole hydrate
HPLC high-performance liquid chromatography
MALDI-TOF matrix-assisted laser desorption ionization-time-of-flight
mTOR mammalian target of rapamycin
NHS N-hydroxysuccinimide
PDC peptide-drug conjugates
PDI polydispersity index
PEG polyethylene glycol
PFA paraformaldehyde
PPD piperidine
ScrErbB2 scrambled peptide
ScrErbB2Lipo non-targeting liposomes conjugated with ScrErbB2
SPPS solid-phase peptide synthesis
TEM transmission electron microscopy
TIS triisopropylsilane